1) Antihepatitis,medicinal
抗乙肝IRNA
2) Ａnti-canine parivirus iRNA
抗犬细小病毒iRNA
3) Hepatitis B Antigen
乙肝抗原
1.
The results indicated that HBV TF could obviously inhibit the adherence of lymphocyte when lymphocyte sensitized by HBV TF were incubated with hepatitis B antigen (HBV Ag),but no such adherence inhibition was found when non specitic transfer factor (TFn), sensitized lumphocytes were incubated with HBV antigen and lymphocytes sensitized by HBV T.
实验结果表明:经HBV-TF致敏的淋巴细胞与乙肝抗原(HBV-Ag)孵育后,显示出明显的粘附抑制活性,而非特异性转移因子(TFn)致敏淋巴细胞与乙肝抗原孵育、HBV-TF致敏淋巴细胞与甲肝抗原(HAV-Ag)孵育或HBV-TF致敏淋巴细胞与1640液(代替抗原液)孵育时均不能表现出这种抑制作用,说明HBV-TF具有抗原特异性免疫活性。
4) Hepatitis B Antibody
乙肝抗体
5) Anti-hepatitis B
抗乙肝
1.
Determination of the Content of Anti-hepatitis B Consituents in Litchi Seed by Spectrophotometric Method;
紫外分光光度法测定荔枝核抗乙肝成分的含量
6) Anti-HBV
抗乙肝病毒
1.
Study on Anti-HBV Effective Parts of Styela plicata Extracted by n-butanol;
皱瘤海鞘正丁醇部位体外抗乙肝病毒的初步研究
2.
Dynamic mathematical model for adefovir dipivoxil anti-HBV treatment;
阿德福韦抗乙肝病毒感染治疗动力学模型
3.
The Effect of Fugan Mixture,the Chinese Herbs,on Anti-HBV and the Balance between Th_1/Th_2 Cytokines;
中药复肝液体外抗乙肝病毒及对Th_1/Th_2细胞平衡的调节作用
补充资料：抗乙肝IRNA
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：治疗乙肝药物。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：治疗乙肝药物。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条